For research and education only · Not reviewed by a medical professional · Disclaimer · Contains affiliate links

Peptide encyclopedia/ 5-Amino-1MQ
Illustration for 5-Amino-1MQ

THE PEPSRADAR ENCYCLOPEDIA

5-Amino-1MQ

NNMT and adipose metabolism

Related compounds · Sources checked 2026-10-04

Read the studies ↓

5-Amino-1MQ AT A GLANCE

The question behind the molecule.

Read findings and limitations ↓
2 selected publicationsIdentity mattersThese experiments do not establish a human weight-loss effect, a clinical regimen, or long-term safety. Different counterions or formulations also need separate identity checks.

What is 5-Amino-1MQ?

5-Amino-1MQ is a small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT). Its featured evidence concerns cultured adipocytes and obese mice, rather than demonstrated weight loss in people.

Biological role or research focus

NNMT and adipose metabolism.

These experiments do not establish a human weight-loss effect, a clinical regimen, or long-term safety. Different counterions or formulations also need separate identity checks.

Role reference: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Names you may encounter

5-amino-1-methylquinolinium

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Small-molecule NNMT inhibitor; not a peptide
Research focus
NNMT and adipose metabolism
Featured evidence
Animal and cell study
Source check
October 4, 2026

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Biology & proposed mechanism

The study investigated whether inhibiting NNMT changes cellular metabolite availability and fat synthesis. Target engagement and a mouse response are separate questions from effective human treatment.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Research context & identity

This profile covers preclinical metabolic research. 5-Amino-1MQ is included as a related compound because it appears in peptide catalogs; its chemistry is not peptidic.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

What does the evidence show?

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Animal and cell study · 2018

NNMT inhibition in diet-induced obesity

What did this publication test, and what did it find?

Population / model
Cultured adipocytes and mice with high-fat-diet-induced obesity.
Study design
Membrane-permeability and enzyme-selectivity experiments followed by metabolic measurements in cells and a short mouse treatment experiment.
Main finding
The investigators reported reduced fat synthesis in adipocytes and lower body weight, white-adipose mass, and cholesterol in treated obese mice, without a change in total food intake.
Limits & context
These experiments do not establish a human weight-loss effect, a clinical regimen, or long-term safety. Different counterions or formulations also need separate identity checks.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Related NNMT-pathway animal study · 2019

NNMT inhibition · aged muscle injury

What did a separate muscle-regeneration experiment test?

Population / model
24-month-old mice with chemically induced tibialis-anterior injury, plus cultured mouse myoblasts.
Study design
Saline versus a small-molecule NNMT inhibitor for one or three weeks; stem-cell activity, muscle-fiber size, and contractile function measured.
Main finding
Treated mice showed increased stem-cell proliferation and fusion, larger regenerating fibers, and approximately 70% higher peak torque than controls in the tested muscle.
How to read it
This extends NNMT-pathway research beyond the earlier obesity model; it is not a human sarcopenia trial.
Limits & context
The abstract names the intervention as NNMTi without stating its exact chemical identity. Compound identity must be checked in the full methods before treating it as direct evidence for a specific 5-amino-1MQ product. Injury-model findings do not establish healthy-human strength or recovery.

Source: NNMT inhibition · aged muscle injury · 2019 ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Search additional PubMed records ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Safety & precautions

Safety & what remains unknown

No observable adverse effects were reported in the short mouse experiment. That observation cannot exclude organ toxicity, interactions, or uncommon harms in people.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Evidence boundaries

These experiments do not establish a human weight-loss effect, a clinical regimen, or long-term safety. Different counterions or formulations also need separate identity checks.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

What are people discussing?

No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.

Watch the source discussions

5 matching video records · 1 with captions indexed.

Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.

Sources & supplier listings

Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.

Named compound · small molecule, not a peptide

5-Amino-1MQ (10mg)

BioLongevity Labs · Vendor-labeled research use only

$74.97

Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.

View seller listing ↗

Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.

Blend · not the isolated compound studied

NAD+ / MOTS-c / 5-Amino-1MQ Blend – 120mg (100mg / 10mg / 10mg)

BioLongevity Labs · Vendor-labeled research use only

$299.99

Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.

Blend ingredients & evidence →

View seller listing ↗

Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.

Named compound · small molecule, not a peptide

5-AMINO-1MQ (50 mg)

American Peptides · Vendor-labeled research use only

$80.00

Listed out of stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.

View seller listing ↗

Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.

Named compound · small molecule, not a peptide

5Amino-1MQ (5 mg / 10 mg)

PSPeptides · Vendor-labeled research use only

$34.99–$49.99

Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.

View seller listing ↗

Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.

Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.

Questions worth asking

  • Is 5-Amino-1MQ a peptide?
  • What material, population, and route were actually studied?
  • These experiments do not establish a human weight-loss effect, a clinical regimen, or long-term safety. Different counterions or formulations also need separate identity checks.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Frequently asked questions

Is 5-Amino-1MQ a peptide?

No. It is a small-molecule NNMT inhibitor. Placement in a research-peptide shop does not change its molecular class.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

Does the publication verify a supplier’s product?

No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.

Source: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. · 2018 ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

WATCH ON PEPSRADAR

Watch video